Martin K. Schmid
Luzern, LU, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Impact of Display Technology and Head-Tracking Latency on the Perceived Quality of a Driving Simulation in Virtual Reality.
Journal: Klinische Monatsblatter fur Augenheilkunde
Published: April 20, 2026
Vision-Related Patient-Reported Outcomes in Randomized Controlled Trials of Age-Related Macular Degeneration: A Systematic Review.
Journal: Ophthalmology science
Published: April 10, 2026
The Role of Fixation in Visual Attention Performance.
Journal: Klinische Monatsblatter fur Augenheilkunde
Published: February 17, 2026
Usability of Augmented Reality Head Mounted Displays (AR HMD) for Reading Studies.
Journal: Klinische Monatsblatter fur Augenheilkunde
Published: February 05, 2026
Prevalence and patterns of anti-angiogenic treatment discontinuation in neovascular age-related macular degeneration-insights from health claims data.
Journal: Eye (London, England)
Published: September 26, 2025
In-Vivo Characterization of Healthy Retinal Pigment Epithelium and Photoreceptor Cells from AO-(T)FI Imaging.
Journal: Vision (Basel, Switzerland)
Published: July 18, 2025
Patient-reported Outcome Measures for Assessing Spectacle Independence after Implantation of Monofocal or Extended Depth of Focus (EDOF) Intraocular Lenses with Various Degrees of Monovision.
Journal: Klinische Monatsblatter fur Augenheilkunde
Published: April 16, 2025
One-year clinical outcomes of four-dose induction versus immediate treat-and-extend faricimab regimens in pretreated neovascular age-related macular degeneration.
Journal: BMC ophthalmology
Published: April 13, 2025
Characterization of retinal pigment epithelium layer in healthy and diseased retinas with high-resolution adaptive optics transscleral flood illumination imaging.
Journal: Acta ophthalmologica
Published: February 08, 2025
Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration.
Journal: Journal of clinical medicine
Published: January 31, 2025
Last Updated: 09/26/2026